Stocks Drift Lower on Wall Street as Gold Hovers Near Record

Stocks are drifting lower on Wall Street Tuesday following a mixed set of earnings reports from big U.S. companies.

Most stocks in the S&P 500 were falling in afternoon trading, but the overall index erased an early loss to drift 0.1% higher. Caution continued to hang over markets, sending Treasury yields a bit lower and gold a bit further into record heights.

The Dow Jones Industrial Average was down 55 points, or 0.2%, at 26,5297, as of 1:50 p.m. Eastern time, and the Nasdaq composite was down 0.2%.

3M was a particularly heavy weight on the market after dropping 4.2%. The maker of n95 masks and various other products for consumers and businesses reported a profit for the latest quarter that fell shy of analysts’ expectations. It said sales trends have been improving this month, but it also said there’s still too much uncertainty given the pandemic to offer any forecasts for its future performance.

McDonald’s lost 2.3% after it said its earnings during the spring plunged by more than two-thirds from a year earlier as the pandemic kept customers away. The results were weaker than Wall Street was expecting.

Ecolab slumped 7.2% for one of the largest losses in the S&P 500 after it said its profit fell more steeply last quarter than analysts expected. The company sells sanitizing and other products to food service companies and other customers, and it was hurt by shutdowns in travel and dining due to the pandemic. It also said, though, that it expects the latest quarter to mark the low point for the company.

Still, nearly 45% of the stocks in the S&P 500 were rising. Utility stocks had some of the biggest gains. Health-care stocks were also holding up better than the rest of the market.

Among them was Pfizer, which climbed 4.5%. It reported a profit for the latest quarter that topped analysts’ expectations, even though it was down by nearly a third from a year earlier. It also nudged up its profit forecast for the full year after announcing the start of a late-stage trial of an experimental COVID-19 vaccine that it’s developing with German partner BioNTech.

They’re the latest earnings reports in what’s to be a deluge this week, with more than a third of the companies in the S&P 500 on the schedule. Profits have so far been better than analysts were expecting, though they’re still on pace to be down nearly 42% from a year earlier, according to FactSet.

The Federal Reserve is also beginning a two-day meeting on interest rates, with an announcement scheduled for Wednesday. Investors largely expect the central bank to keep short-term rates at their record low, but they’re also looking to hear what it says about how long they may stay there.

The Fed helped launch the stock market’s recovery in late March after slashing interest rates and promising to buy Treasurys, corporate bonds and other debt to prop up the economy. On Tuesday, the Fed said it will extend the lives of seven of the lending programs by three months through the end of the year, an acknowledgment of the severity of the recession.

The S&P 500 is back to within 5% of its record set in February, after earlier being down nearly 34%.

Massive aid from Congress also helped that turnaround to erupt, but a big part of it is about to expire on Friday: $600 in weekly unemployment benefits. Such support has taken on more importance as a report last week showed an unexpected tick higher in the number of workers filing for jobless benefits. Rising coronavirus counts across the Sun Belt have pushed many businesses to close down again.

Many investors are hopeful that Democrats and Republicans can reach a deal on more aid for the 16 million or so Americans who are getting unemployment benefits, even though the two sides still seem to be far apart.

“They’re going to get to a resolution eventually, it’s just how the sausage is made is going to take a little longer and that’s causing a little trepidation,” said Ryan Detrick, chief investment strategist for LPL Financial.

The yield on the 10-year Treasury note edged dipped to 0.57% from 0.60% late Monday. It tends to move with investors’ expectations for the economy and inflation.

Gold, which has rocketed this year on worries about the economy, rose $13.70 to $1,944.70 per ounce. It earlier touched $1,974.40 to set an intraday record for the second straight day.

Benchmark U.S. crude oil fell 1.3% to $41.07 per barrel. Brent crude, the international standard, slipped 0.7% to $43.61 per barrel.

Stock markets overseas were mixed. In Asia, Japan’s Nikkei 225 index slipped 0.3%, but South Korea’s Kospi gained 1.8% and the Hang Seng in Hong Kong rose 0.7%. Stocks in Shanghai added 0.7%.

In Europe, Germany’s DAX was virtually flat, and France’s CAC 40 fell 0.2%. The FTSE 100 in London rose 0.4%.